Early Phase 1 Thalassemia Clinical Trials
6 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–6 of 6 trials
Recruiting
Early Phase 1
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Sickle Cell DiseaseThalassemiaHemoglobinopathy
National Heart, Lung, and Blood Institute (NHLBI)100 enrolled1 locationNCT06313398
Recruiting
Early Phase 1
Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients
Thalassemia
Shenzhen Hemogen10 enrolled1 locationNCT05745532
Recruiting
Early Phase 1
the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia
Thalassemia
Shenzhen Hemogen3 enrolled1 locationNCT05851105
Recruiting
Early Phase 1
the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
Thalassemia
Shenzhen Hemogen3 enrolled1 locationNCT05864170
Recruiting
Early Phase 1
Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease
Hereditary DiseasesHemoglobinopathiesAlpha Thalassemia Hemoglobin H Constant Spring
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army5 enrolled1 locationNCT06107400
Recruiting
Early Phase 1
A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
Transfusion Dependent Beta-Thalassemia
First Affiliated Hospital of Guangxi Medical University5 enrolled1 locationNCT05762510